NCT00296478View on ClinicalTrials.gov

Multi-Center, Randomized, Open-Label, Parallel Group Study of a Vaginal Micronized Progesterone Tablet (Endometrin®) Compared to Crinone 8% Vaginal Gel in Female Patients Undergoing In-Vitro Fertilization (IVF)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,211

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

April 30, 2006

Study Completion Date

July 31, 2006

Conditions
Fertility
Interventions
DRUG

Endometrin

Endometrin 100mg BID x 10weeks

DRUG

Endometrin

Endometrin 100mg TID x 10weeks

DRUG

Crinone

Crinone QD x 10weeks

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY

NCT00296478 - Multi-Center, Randomized, Open-Label, Parallel Group Study of a Vaginal Micronized Progesterone Tablet (Endometrin®) Compared to Crinone 8% Vaginal Gel in Female Patients Undergoing In-Vitro Fertilization (IVF) | Biotech Hunter | Biotech Hunter